Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates.
about
Detection and quantification of gene expression in environmental bacteriologyArt-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosaPseudomonas aeruginosa population structure revisited.Genomewide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosaActivity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strainsTrends of the major porin gene (ompF) evolution: insight from the genus Yersinia.Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolatesAntibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.Establishment of real-time quantitative reverse transcription polymerase chain reaction assay for transcriptional analysis of duck enteritis virus UL55 gene.Whole genome and transcriptome analyses of environmental antibiotic sensitive and multi-resistant Pseudomonas aeruginosa isolates exposed to waste water and tap water.Emergence of carbapenem resistance due to the novel insertion sequence ISPa8 in Pseudomonas aeruginosaHorizontal gene transfer and assortative recombination within the Acinetobacter baumannii clinical population provide genetic diversity at the single carO gene, encoding a major outer membrane protein channelAlterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.Pyoverdine receptor: a case of positive Darwinian selection in Pseudomonas aeruginosa.Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.Identification of 1-((2,4-Dichlorophenethyl)Amino)-3-Phenoxypropan-2-ol, a Novel Antibacterial Compound Active against Persisters of Pseudomonas aeruginosa.Carbapenems in the USA: focus on doripenem.Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies.Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections.Mutant Alleles of lptD Increase the Permeability of Pseudomonas aeruginosa and Define Determinants of Intrinsic Resistance to Antibiotics.Development of carbapenem resistance in Pseudomonas aeruginosa is associated with OprD polymorphisms, particularly the amino acid substitution at codon 170.Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.Identification of unique in-frame deletions in OprD among clinical isolates of Pseudomonas aeruginosa.Research of the heteroresistance of Pseudomonas aeruginosa to imipenem.Fitness trade-offs explain low levels of persister cells in the opportunistic pathogen Pseudomonas aeruginosa.Label-free SRM-based relative quantification of antibiotic resistance mechanisms in Pseudomonas aeruginosa clinical isolates.A novel Pseudomonas aeruginosa strain with an oprD mutation in relation to a nosocomial respiratory infection outbreak in an intensive care unitActivity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.Diversity of Antimicrobial Resistance and Virulence Determinants in Pseudomonas aeruginosa Associated with Fresh Vegetables.Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.A novel insertion sequence, ISPA26, in oprD of Pseudomonas aeruginosa is associated with carbapenem resistance.Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.Structure, function and regulation of Pseudomonas aeruginosa porins.Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy.Prevalence and antibiotic resistance of Pseudomonas aeruginosa in water samples in central Italy and molecular characterization of oprD in imipenem resistant isolates.Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance.Probing the sRNA regulatory landscape of P. aeruginosa: post-transcriptional control of determinants of pathogenicity and antibiotic susceptibility.
P2860
Q24564292-39909457-E1FD-46F0-9F52-9C8F80BCF15FQ30581467-7374625A-5AE0-4550-B7AA-2C0CB5D3D1E0Q30913394-27AF37A2-DFF2-4934-9E4E-652BEA1CB833Q33424246-B66FB945-9C0D-4DAD-8925-CBEB1CA1AEFCQ33613660-814203AF-8FE8-4A2B-88F8-CFD35B13E473Q33926931-78F965AF-8A9B-4024-9373-70337012FF01Q34648729-4B3C7E11-6D36-47A1-802F-D2FAFCEF54F2Q35007624-E2B40828-3F7C-432A-A5DA-E797E959A483Q35061495-808E4861-10FD-479A-B6D8-FE540D4AC84AQ35062974-ACFD2757-D4FF-48F5-B092-6A359697320DQ35116174-6F627A86-1491-477D-8AF5-EC7DF73F7537Q35192521-7C320476-286B-46C1-9165-3495A3FDC6DAQ35867456-B35E1579-3ED2-433B-B242-D7883C19FF86Q36113710-534DFDF5-EFD2-45E5-8079-957AA4631B9EQ36172484-82296C33-71D6-48A7-8C81-297F74BBFDF6Q36313186-DCF199D5-DB9E-4EEC-A569-31F045D1EB09Q36409828-45142255-637A-4656-8AF0-DED312AF6ACAQ36960048-42A67BF8-2648-4E66-887D-0AB95E4FB929Q37317645-FFB9D41D-1D27-4C49-8B69-E91F90F07CD7Q37598703-5C707353-B499-4CA0-98DE-1A1DD24E41D5Q38367630-BD91527D-2B2E-4A8B-90E3-5E1B57DB53CDQ40202111-561280EF-972D-4F3D-BBA7-637FDB1391A2Q40334912-8E74A528-2BC3-4254-A297-A448FA8278AEQ40716933-8093733F-18C2-4C7D-A436-2A671C2E6FEDQ41129709-CF7173E5-4E4C-4339-A250-C01490AAEDE4Q41345292-5EC28D8B-530F-445A-9812-54465F17CA8DQ41465136-656D0B1C-886D-41F8-BE77-B2998289C66CQ41710408-33BB00D1-CB7E-44F3-B3B6-630F99423A9BQ41839265-88BF4D08-B706-43C1-A44C-8A3B35AF2090Q41993179-F2DC7282-8E85-45E0-AABF-27FC57738EDFQ42612014-4E69C1AC-2F9F-49F3-9E77-87713D780BD0Q42627718-85B6A3D5-6A5C-4FF6-8870-32B7B56151C2Q45265795-B47B54F8-A742-4608-A510-00BE0949D089Q45550772-F39CA14C-9D6F-4867-BFAE-B3165632D47BQ46293888-9B40B12E-2D48-465B-8F6B-56B3FA3BA74CQ46412289-3D6170D6-E0BB-4F44-8444-214EC427DED2Q46608208-BF58C924-31EB-45DF-888C-900E889AE5BFQ47133313-ED13E357-C511-4753-89CD-FBF45CA9D648Q47748447-EBA97148-DFB1-4F0B-8C13-099FB005AC6CQ48247281-0F02227B-3E4D-40C2-A6EC-C925665CE96C
P2860
Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Analysis of the Pseudomonas ae ...... al and environmental isolates.
@en
Analysis of the Pseudomonas ae ...... al and environmental isolates.
@nl
type
label
Analysis of the Pseudomonas ae ...... al and environmental isolates.
@en
Analysis of the Pseudomonas ae ...... al and environmental isolates.
@nl
prefLabel
Analysis of the Pseudomonas ae ...... al and environmental isolates.
@en
Analysis of the Pseudomonas ae ...... al and environmental isolates.
@nl
P2093
P2860
P1476
Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates
@en
P2093
Alain Vanderkelen
Daniel De Vos
Dimitris Mossialos
Martin Zizi
Pierre Cornelis
P2860
P304
P356
10.1046/J.1462-2920.2002.00281.X
P577
2002-12-01T00:00:00Z